FDG uptake in lymph-nodes of HIV+ and tuberculosis patients: Implications for cancer staging

Quarterly Journal of Nuclear Medicine and Molecular Imaging

Volumn 54, Issue 6, 2010, Pages 698-703

  Sathekge, M ^a   Maes, A ^a,b   Kgomo, M ^c   Pottel, H ^d   Stolz, A ^e   Van De Wiele, C ^f  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b Department of Internal Medicine   (South Africa)

^c Department of Nuclear Medicine ^*  (Belgium)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e UNIVERSITY OF LEUVEN   (Belgium)

^f GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

HIV; Lymph nodes; Neoplasms; Positron emission tomography, fluorodeoxyglucose F18; Tuberculosis

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; AXILLARY LYMPH NODE; CANCER PATIENT; CANCER STAGING; CERVICAL LYMPH NODE; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG UPTAKE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INGUINAL LYMPH NODE; LATENT TUBERCULOSIS; LUNG HILUS LYMPH NODE; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; PORTA HEPATIC LYMPH NODE;

ADULT; FEMALE; FLUORODEOXYGLUCOSE F18; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

EID: 79952624129     PISSN: 18244785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Bonnet F, Chêne G. Evolving epidemiology of malignancies in HIV Curr Opin Oncol 2008;20:534-40.
2. Powles T, Robinson D, Stebbing J, Shamash J, Nelson M, Gazzard B et al. Highly active antiretroviral therapy and the incidence of non-aids-defining cancers in people with hiv infection. J Clin Oncol 2009;27:884-90.
3. Bedimo R. Non-AIDS-defining malignancies among HIV-infected patients in the highly active antiretroviral therapy era. Curr HIV/AIDS Rep 2008;5:140-9.
4. Crum-Cianflone N, Hullsiek K. Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy:a 20-year cohort study. AIDS 2009;2:23:41-50.
5. Mayor A, Gomez M, Rios-Olivares E, Hunter-Mellado R. AIDS-defining neoplasm prevalence in a cohort of HIV-infected patients, before and after highly active antiretroviral therapy. Ethn Dis 2008;18:S2:189-94.
6. Chitale A. Cancer and AIDS. Indian J Pathol Microbiol 2005;48:151-60.
7. Scharko A, Perlman S, Pyzalski R, Graziano F, Sosman J, Pauza C et al. Whole-body positron emission tomography in patients with HIV-1 infection. Lancet 2003;20:959-61. (Pubitemid 37159292)
8. Iyengar S, Chin B, Margolick J, Sabundayo B, Schwartz D. Anatomical loci of HIV-associated immune activation and association with viraemia. Lancet 2003;20:945-50. (Pubitemid 37168049)
9. Brust D, Polis M, Davey R, Hahn H, Bacharach S, Whatley M et al. Fluorodeoxyglucose imaging in healthy subjects with HIV infection:impact of disease stage and therapy on pattern of nodal activation. AIDS 2006;20:495-503.
10. Lucignani G, Orunesu E, Cesari M, Marzo K, Pacei M, Bechi G et al. A. FDG-PET imaging in HIV-infected subjects:relation with therapy and immunovirological variables. Eur J Nucl Med Mol Imaging. 2008, epub ahead of print: DOI 10.1007/s00259-008-1023-7.
11. El-Sadr W, Tsiouris S. HIV-associated tuberculosis:diagnostic and treatment challenges. Semin Respir Crit Care Med 2008;29:525-31.
12. Golden M, Vikram H. Extra-pulmonary tuberculosis: an overview. Am Fam Physician 2005;72:1761-8.
13. Arciniegas W, Orjuela D. Extra-pulmonary tuberculosis: a review of 102 cases in Pereira, Colombia. Biomedica 2006;26:71-80.
14. Bental M, Deutsch C. Metabolic changes in activated Tcells: an NMR study of human peripheral blood lymphocytes. Magn Reson Med 1993;29:317-26. (Pubitemid 23114497)
15. Marjanovic S, Skog S, Heiden T, Tribukait B, Nelson BD. Expression of glycolytic isoenzymes in activated human peripheral lymphocytes: cell cycle analysis using flow cytometry. Exp Cell Res 1991;193:425-31. (Pubitemid 121005685)
16. Kwan A, Seltzer M, Czernin J, Chou M, Kao C. Characterization of hilar lymph node by 18F-fluro-2-deoxyglucose positron emission tomography in healthy subjects. Anticancer Res 2001;21:701-6. (Pubitemid 32267596)
17. Scharko A, Perlman S, Hinds P, Hanson J, Uno H, Pauza C. Whole body positron emission tomography imaging of simian immunodeficiency virus-infected rhesus macaques. Proc Natl Acad Sci USA 1996;93:6425-30.
18. Wallace M, Pyzalski R, Horejsh D, Brown C, Djauani M, Lu Y et al. Whole body positron emission tomography imaging of activated lymphoid tissues during acute simian-human immunodeficiency virus 89.6PD infection in rhesus macaques. Virology. 2000;274:255-61.
19. rd ed. Philadelphia , PA: WB Saunders; 1967. p. 31-7.
20. Adams D. The granulomatous inflammatory response:a review. Am J Pathol 1976;84:161-91.
21. rd edition. New York, NY: McGraw-Hill; 1998. p. 2447-71.
22. Cazin M, Paluszezal D, Bianchi A, Cazin J, Aerts C, Voisin C. Effects of anaerobosis upon morphology and energy metabolism of alveloar macrophages cultured in gas phase. Eur Respir J 1990;3:1015-22.
23. Hara T, Kosaka N, Suzuki T, Kudo K, Niino H. Uptake rates of 18F-fluorodeoxyglucose and 11C-choline in lung cancer and pulmonary tuberculosis. Chest 2003;124:893-901.
24. Deol P, Vohra R, Saini A, Singh H, Chandra H, Chopra P et al. Role of mycobacterium tuberculosis Ser/thre kinase PknF:in glucose transport and cell division. J Bacteriol 2005;187:3415-20.
25. Hopewell P, Bloom B. Tuberculosis and other mycobacterial diseases. In: Murray J, Nadel K, editors. Respiratory Medicine, 3rd ed. Philadelphia, PA, WB Saunders Company; 2000. p. 1043-105.
26. Daley C, Small P, Schecter G, Schoolnik G, Mc Adam R, Jacobs W et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus:an analysis using restriction fragment length polymorphism. N Engl J Med 1992;326:321-35.
27. Goletti D, Weissman D, Jackson R, Graham N, Vlahou D, Klein R et al. Effect of Mycobacterium tuberculosis on HIV replication. J Immunol 1996;157:1271-8. (Pubitemid 126449644)
28. Wallis R, Vjecha M, Amir Thamasseb M, Okwera A, Byekwaso F, Nyole S et al. Influence of tuberculosis on human immunodeficiency virus (HIV-1) :enhanced cytokine expression and elevated beta-2-microglobulin HIV-1 associated tuberculosis. J Infect Dis 1993;167:43-8. (Pubitemid 23002835)
29. Shattock R, Friedland J, Griffin G. Modulation of HIV transcription in and release from monocytic cells following phagocytosis of Mycobacterium tuberculosis. Res Virol 1993;144:7-12. (Pubitemid 23068327)
30. Lederman M, Georges D, Kusner D, Mudido P, Giam C, Toosi Z. Mycobacterium tuberculosis and its purified protein derivative activate expression of the human immunodeficiency virus. J AIDS 1994;7:727-33.
31. Aoki Y, Tosato G. Neoplastic conditions in the context of HIV1-infection. Curr HIV Res 2004;2:343-49. (Pubitemid 39242964)